Next Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Next Financial Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$147K	Sell	1,311 -12	-0.9%	-$1.45K	0.01%	1015
2021 Q3	$167K	Sell	1,323 -81	-6%	-$10.4K	0.01%	925
2021 Q2	$190K	Sell	1,404 -10,054	-88%	-$1.32M	0.02%	843
2021 Q1	$1.55M	Buy	11,458 +10,623	+1,272%	+$1.59M	0.14%	166
2020 Q4	$118K	Buy	835 +143	+21%	+$18.3K	0.01%	893
2020 Q3	$77K	Sell	692 -8,712	-93%	-$977K	0.01%	960
2020 Q2	$1.05M	Buy	9,404 +5,108	+119%	+$503K	0.12%	185
2020 Q1	$333K	Sell	4,296 -1,841	-30%	-$163K	0.04%	369
2019 Q4	$584K	Buy	6,137 +5,555	+954%	+$481K	0.06%	333
2019 Q3	$44K	Sell	582 -109	-16%	-$9.06K	﹤0.01%	1184
2019 Q2	$61K	Buy	691 +688	+22,933%	+$58.7K	0.01%	1104
2019 Q1	$0	Sell	3 -688	-100%	-$58.5K	﹤0.01%	2141
2018 Q4	$50K	Buy	691 +423	+158%	+$34.1K	0.01%	802
2018 Q3	$26K	Buy	+268	New	+$26K	0.01%	709
2017 Q4	–	Sell	-603	Closed	-$52K	–	1438
2017 Q3	$52K	Sell	603 -916	-60%	-$73.4K	0.01%	691
2017 Q2	$117K	Buy	1,519 +281	+23%	+$19.9K	0.03%	493
2017 Q1	$88K	Sell	1,238 -2,989	-71%	-$201K	0.02%	532
2016 Q4	$250K	Buy	4,227 +288	+7%	+$17.8K	0.04%	409
2016 Q3	$261K	Buy	3,939 +2,370	+151%	+$147K	0.05%	387
2016 Q2	$84K	Hold	1,569	–	–	0.03%	504
2016 Q1	$81K	Sell	1,569 -2,039	-57%	-$106K	0.03%	486
2015 Q4	$253K	Hold	3,608	–	–	0.09%	223
2015 Q3	$224K	Buy	3,608 +1,697	+89%	+$134K	0.08%	257
2015 Q2	$160K	Buy	1,911 +870	+84%	+$67.7K	0.06%	353
2015 Q1	$78K	Hold	1,041	–	–	0.03%	539
2014 Q4	$65K	Sell	1,041 -1,725	-62%	-$98.3K	0.02%	575
2014 Q3	$144K	Buy	2,766 +2,760	+46,000%	+$141K	0.03%	548
2014 Q2	$0	Buy	+6	New	+$271	﹤0.01%	1235

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Next Financial Group's XBI Position: Q4 2021 in Review

Next Financial Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.91% in Q4 2021, selling an estimated $1.45K and leaving 1,311 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #1015.

Next Financial Group first reported a position in XBI in Q2 2014 and has held it in 28 quarters since. The position peaked at $1.55M in Q1 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Next Financial Group held 1,311 shares of State Street SPDR S&P Biotech ETF worth $147K as of Q4 2021.
Next Financial Group sold 12 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $1.45K.
State Street SPDR S&P Biotech ETF made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1015 holding.
Next Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 28 quarters since.
Next Financial Group's State Street SPDR S&P Biotech ETF position peaked at $1.55M in Q1 2021.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.